Body Mass Index, Coronary Artery Calcification, and Kidney Function Decline in Stage 3 to 5 Chronic Kidney Disease Patients

Journal of Renal Nutrition

Volumn 23, Issue 1, 2013, Pages 4-11

  Garland, Jocelyn S ^a   Holden, Rachel M ^a   Hopman, Wilma M ^a   Gill, Sudeep S ^a   Nolan, Robert L ^a   Morton, A Ross ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CALCINOSIS; CANADA; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BODY MASS INDEX; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; CREATININE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONTARIO; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84871445830     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.12.008     Document Type: Article

References (31)

1. Matsuoka M., Iseki K., Tamashiro M., et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004, 8:54-58.
2. Watanabe R., Lemos M.M., Manfredi S.R., Draibe S.A., Canziani M.E. Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up. Clin J Am Soc Nephrol 2010, 5:189-194.
3. Garland J.S., Holden R.M., Groome P.A., et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis 2008, 52:849-858.
4. Holden R.M., Morton A.R., Garland J.S., Pavlov A., Day A.G., Booth S.L. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:590-597.
5. Russo D., Miranda I., Ruocco C., et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007, 72:1255-1261.
6. Block G.A., Spiegel D.M., Ehrlich J., et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005, 68:1815-1824.
7. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2004, 39(suppl 1):S1-S266.
8. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45. Canadian Cardiovascular Society.
9. Hemingway H., Fitzpatrick N.K., Gnani S., et al. Prospective validity of measuring angina severity with Canadian Cardiovascular Society class: the ACRE study. Can J Cardiol 2004, 20:305-309.
10. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary: expert panel on the identification, evaluation, and treatment of overweight in adults. Am J Clin Nutr 1998, 68:899-917.
11. Hemmelgarn B.R., McAlister F.A., Grover S., et al. Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: part I-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2006, 22:573-581.
12. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003, 27(suppl 2):S1-S152.
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
14. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 15(145):247-254. Chronic Kidney Disease Epidemiology Collaboration.
15. Wexler L., Brundage B., Crouse J., et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Circulation 1996, 94:1175-1192. Writing Group.
16. Agatston A.S., Janowitz W.R., Hildner F. Quantification of coronary artery calcium using ultra fast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
17. Rosner B. Fundamentals of Biostatistics 2006, Duxbury Press, Pacific Grove, CA. 6th ed.
18. Levin A., Djurdjev O., Beaulieu M., Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008, 52:661-671.
19. Covic A., Kanbay M., Voroneanu L., et al. Vascular calcification in chronic kidney disease. Clin Sci (Lond) 2010, 119:111-121.
20. Ketteler M., Bongartz P., Westenfeld R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003, 361:827-833.
21. Reynolds J.L., Joannides A.J., Skepper J.N., et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004, 15:2857-2867.
22. Budoff M.J., Rader D.J., Reilly M.P., et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 2011, 58:519-526.
23. Tomiyama C., Higa A., Dalboni M.A., et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant 2006, 21:2464-2471.
24. Bellasi A., Kooienga L., Block G.A., Veledar E., Spiegel D.M., Raggi P. How long is the warranty period for nil or low coronary artery calcium in patients new to.hemodialysis?. J Nephrol 2009, 22:255-262.
25. Gutiérrez O.M., Januzzi J.L., Isakova T., et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009, 119:2545-2552.
26. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 2004, 17:229-232.
27. Noori N., Hosseinpanah F., Nasiri A.A., Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr 2009, 19:228-237.
28. Elsayed E.F., Sarnak M.J., Tighiouart H., et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008, 52:29-38.
29. Elsayed E.F., Tighiouart H., Weiner D.E., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 2008, 52:49-57.
30. Collins A.J., Foley R.N., Gilbertson D.T., Chen S.C. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009, 4(suppl 1):S5-S11.
31. Klarenbach S., Manns B. Economic evaluation of dialysis therapies. Semin Nephrol 2009, 29:524-532.